Pfisterer

Pfisterer increased revenue in the first half of 2026 by more than 20% to €256.70 million and improved gross profit to €107.77 million. EBITDA climbed to €51.51 million (EBITDA margin 20.1%), adjusted EBITDA to €52.40 million. The management board confirmed the revenue guidance for 2026 with expected growth of 12–17%; the order book remains visible into fiscal 2027 at €340.26 million. Analysts reiterated the €115.00 price target and the "Buy" rating. » More on finanzen.net

PFISTERER reported a 20.2% revenue increase and a 32.7% rise in adjusted EBITDA in the first half of 2026; Q2 revenue reached a record €129.8m. The order backlog grew to €340m, the gross margin stayed above 40% for four consecutive quarters, and profit for the period increased markedly. Management confirmed the full‑year forecast of 12–17% revenue growth and expects a stronger second half, yet the shares fell after the figures. Analysts still see upside potential, but risks remain from slower order intake and regional margin fluctuations. » More on de.investing.com

Pfisterer reported to BaFin that supervisory board member Schefold reduced his position by 10,000 shares on 26 May 2026 at EUR 100.25 each; the confirmation was received on 29 May 2026. On the day of the announcement the share barely moved and traded near EUR 100 in FSE trading, with low daily turnover. Already on 26 May 2026 Prof. Dr. Wolfgang Blättchen also exited the portfolio with 60,000 Pfisterer shares. Pfisterer has a market capitalization of around EUR 1.88 billion and a free float of 18,098,102 shares. » More on finanzen.net